An international team of scientists performed theoretical and experimental research on a new high-temperature superconductor, yttrium hydride (YH6). Until 2015, 138 K (or 166 K under pressure) was the record of high-temperature superconductivity. Room-temperature superconductivity, which would have been laughable five years ago, has become a reality. Right now, the whole point is to attain room-temperature superconductivity at lower pressures. Scientists reported that YH6 displays a superconducting transition at ?224 K at 166 GPa.
E-Mail
IMAGE: Researchers at The University of Tokyo use the mathematics of adaptive learning and artificial intelligence to describe how T helper cells adjust the response of the vertebrate immune system, which. view more
Credit: Institute of Industrial Science, the University of Tokyo
Tokyo, Japan - Scientists from the Institute of Industrial Science at The University of Tokyo demonstrated how the adaptive immune system uses a method similar to reinforcement learning to control the immune reaction to repeat infections. This work may lead to significant improvements in vaccine development and interventions to boost the immune system.
In the human body, the adaptive immune system fights germs by remembering previous infections so it can respond quickly if the same pathogens return. This complex process depends on the cooperation of many cell types. Among these are T helpers, which assist by coordinating the response of other parts of the immune system called effector
E-Mail
A gene therapy for chronic pain could offer a safer, non-addictive alternative to opioids. Researchers at the University of California San Diego developed the new therapy, which works by temporarily repressing a gene involved in sensing pain. It increased pain tolerance in mice, lowered their sensitivity to pain and provided months of pain relief without causing numbness.
The researchers report their findings in a paper published Mar. 10 in
Science Translational Medicine.
The gene therapy could be used to treat a broad range of chronic pain conditions, from lower back pain to rare neuropathic pain disorders conditions for which opioid painkillers are the current standard of care.
E-Mail
IMAGE: Hayley Yaglom, TGen genomic epidemiologist and lead researcher on a project to test pets for COVID-19, takes a blood sample from a dog. view more
Credit: Photo: Courtesy of TGen.
PHOENIX, Ariz. March 10, 2021 The Translational Genomics Research Institute (TGen), an affiliate of City of Hope, announced today the start a new scientific study: Testing pets of those Arizonans who have contracted COVID-19.
No pets will be harmed during this study as all sample collections will be performed by trained veterinary staff. Among the more than 120 pets that have tested positive nationwide, there is no evidence suggesting that pets can spread the virus to humans.
As plastic debris weathers in aquatic environments, it can shed tiny nanoplastics. Although scientists have a good understanding of how these particles form, they still don t have a good grasp of where all the fragments end up. Now, researchers reporting in ACS